|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.8 INR | -1.32% |
|
-5.77% | +9.04% |
| 05-30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
| 05-13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
Alembic Ltd. announced that Mr. Drigesh Mittal has been appointed as the Dy. Company Secretary and Compliance Officer of the company with effect from June 15, 2015.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.04% | 308M | |
| +3.93% | 27.42B | |
| -10.72% | 26.45B | |
| +20.29% | 24.75B | |
| +10.41% | 24.3B | |
| +9.59% | 21.46B | |
| +31.16% | 20.54B | |
| -3.54% | 18.05B | |
| +3.23% | 17.09B | |
| +28.88% | 15.45B |
ALEMBIC LIMITED 
